M
Michel H. Hof
Researcher at University of Amsterdam
Publications - 36
Citations - 1240
Michel H. Hof is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Population & Pregnancy. The author has an hindex of 14, co-authored 32 publications receiving 822 citations.
Papers
More filters
Journal ArticleDOI
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
Ilse K. Luirink,Albert Wiegman,D Meeike Kusters,Michel H. Hof,Jaap W. Groothoff,Eric de Groot,John J.P. Kastelein,Barbara A. Hutten +7 more
TL;DR: In this study, initiation of statin therapy during childhood in patients with familial hypercholesterolemia slowed the progression of carotid intima-media thickness and reduced the risk of cardiovascular disease in adulthood.
Journal ArticleDOI
Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers
Joost Besseling,Iris Kindt,Michel H. Hof,John J.P. Kastelein,Barbara A. Hutten,G. Kees Hovingh +5 more
TL;DR: Patients with severe HeFH are at increased CVD risk compared to non-severe HeFH patients, which underscores the need for more aggressive LDL-C lowering these patients.
Journal ArticleDOI
From population reference to national standard: new and improved birthweight charts.
Liset Hoftiezer,Michel H. Hof,Joyce Dijs-Elsinga,Marije Hogeveen,Chantal W P M Hukkelhoven,Richard A. van Lingen +5 more
TL;DR: Excluding risk factors that cause lower birthweights results in prescriptive birthweight charts that are more akin to fetal‐weight charts, enabling proper discrimination between normal and abnormal birthweight.
Journal ArticleDOI
Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial
Hannah S. van Meurs,Parvin Tajik,Michel H. Hof,Ignace Vergote,Gemma G. Kenter,Ben W.J. Mol,Marrije R. Buist,Patrick M. Bossuyt +7 more
TL;DR: It was found in this exploratory analysis that patients with stage IIIC and less extensive metastatic tumours had higher survival with primary surgery, while patients withStage IV disease and large metastatic cancer patients hadHigher survival with neoadjuvant chemotherapy.
Journal ArticleDOI
The Effect of Interpregnancy Interval on the Recurrence Rate of Spontaneous Preterm Birth: A Retrospective Cohort Study.
Bouchra Koullali,Esme I. Kamphuis,Esme I. Kamphuis,Michel H. Hof,Sarah A. Robertson,Eva Pajkrt,Christianne J.M. de Groot,Ben W.J. Mol,Anita C.J. Ravelli +8 more
TL;DR: In women with a previous spontaneous preterm birth, a short interpregnancy interval has a strong impact on the risk of pre term birth before 37 weeks and low birth weight in the next pregnancy, irrespective of the type of analysis performed.